|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
AU584417B2
(en)
|
1985-04-01 |
1989-05-25 |
Lonza Group Ag |
Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
GB9818110D0
(en)
|
1998-08-19 |
1998-10-14 |
Weston Medical Ltd |
Needleless injectors and other devices
|
|
US6096002A
(en)
|
1998-11-18 |
2000-08-01 |
Bioject, Inc. |
NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method
|
|
US7658921B2
(en)
|
2000-12-12 |
2010-02-09 |
Medimmune, Llc |
Molecules with extended half-lives, compositions and uses thereof
|
|
PT1355919E
(pt)
|
2000-12-12 |
2011-03-02 |
Medimmune Llc |
Moléculas com semivida longa, composições que as contêm e suas utilizações
|
|
US7217797B2
(en)
|
2002-10-15 |
2007-05-15 |
Pdl Biopharma, Inc. |
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
|
|
JP2007531707A
(ja)
|
2003-10-15 |
2007-11-08 |
ピーディーエル バイオファーマ， インコーポレイテッド |
ＩＧの重鎖定常領域の位置２５０、３１４および／または４２８の変異誘発によるＦｃ融合タンパク質血清半減期の改変
|
|
US8367805B2
(en)
|
2004-11-12 |
2013-02-05 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
JP6701079B2
(ja)
|
2013-12-20 |
2020-05-27 |
インターベット インターナショナル ベー． フェー． |
ヒトｐｄ−１に対するイヌ化マウス抗体
|
|
WO2018073185A1
(en)
|
2016-10-17 |
2018-04-26 |
Vetoquinol Sa |
Modified antibody constant region
|
|
JP7399880B2
(ja)
|
2018-01-26 |
2023-12-18 |
ジェンザイム・コーポレーション |
ＦｃＲｎへの増強された結合及び延長された半減期を有するＦｃ変異体
|
|
CN113194984A
(zh)
|
2018-10-18 |
2021-07-30 |
金德雷德生物科学股份有限公司 |
兽用的与新生儿Fc受体(FcRn)结合改变的Fc变体
|
|
CN113227134A
(zh)
*
|
2018-12-05 |
2021-08-06 |
株式会社梅花治疗 |
抗体的Fc区变体
|
|
US11542333B2
(en)
*
|
2019-01-03 |
2023-01-03 |
Invetx, Inc. |
Compositions for increasing half-life of a therapeutic agent in canines and methods of use
|
|
US20220169740A1
(en)
|
2019-03-20 |
2022-06-02 |
Kindred Biosciences, Inc. |
NGF Antagonists for Medical Use
|
|
FR3104217B1
(fr)
|
2019-12-10 |
2021-12-24 |
Innov Shoes |
Dispositif d’assemblage amovible entre deux pièces
|
|
MX2022007636A
(es)
*
|
2019-12-20 |
2022-07-19 |
Intervet Int Bv |
Anticuerpos biespecificos caninizados y pares de union biespecificos para el tratamiento contra dermatitis atopica.
|
|
US11434276B2
(en)
|
2020-05-11 |
2022-09-06 |
Invetx, Inc. |
Polypeptides with altered binding to neonatal Fc receptor (FcRn) and methods of use
|